Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (461-470 of 509) with videos related to

Pageof 51
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2018
No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) ProjectJames H Cole, Matthan W A Caan, Jonathan Underwood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2014
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patientsSuzanne M Ingle, Margaret T May, M John Gill, et al.
Plos One|October 25, 2024
HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015Andrew Atkinson, David Kraus, Nicolas Banholzer, et al.
AIDS (London, England)|November 15, 2017
Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistanceSara Lodi, Huldrych F Günthard, David Dunn, et al.
BMC Infectious Diseases|November 10, 2016
Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint projectNicole Ngo-Giang-Huong, Linda Wittkop, Ali Judd, et al.
Open Forum Infectious Diseases|July 17, 2024
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North AmericaJulie Ambia, Suzanne M Ingle, Kathleen McGinnis, et al.
AIDS (London, England)|May 31, 2013
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009Sophie Abgrall, Suzanne M Ingle, Margaret T May, et al.
The Journal of Infectious Diseases|August 26, 2025
Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort StudyMarco Labarile, Isabella C Schoepf, Chloé Pasin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2016
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimenAndrea De Luca, Philippe Flandre, David Dunn, et al.
Pageof 51

Showing results (461-470 of 509) with videos related to

Sort By:
Pageof 51
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2018
No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) ProjectJames H Cole, Matthan W A Caan, Jonathan Underwood, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2014
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patientsSuzanne M Ingle, Margaret T May, M John Gill, et al.
Plos One|October 25, 2024
HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015Andrew Atkinson, David Kraus, Nicolas Banholzer, et al.
AIDS (London, England)|November 15, 2017
Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistanceSara Lodi, Huldrych F Günthard, David Dunn, et al.
BMC Infectious Diseases|November 10, 2016
Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint projectNicole Ngo-Giang-Huong, Linda Wittkop, Ali Judd, et al.
Open Forum Infectious Diseases|July 17, 2024
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North AmericaJulie Ambia, Suzanne M Ingle, Kathleen McGinnis, et al.
AIDS (London, England)|May 31, 2013
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009Sophie Abgrall, Suzanne M Ingle, Margaret T May, et al.
The Journal of Infectious Diseases|August 26, 2025
Untargeted Metabolite Profile Associations with Body Mass Index, Waist-Hip Ratio, and Antiretroviral Therapy in >1300 People with HIV: the Swiss HIV Cohort StudyMarco Labarile, Isabella C Schoepf, Chloé Pasin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2016
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimenAndrea De Luca, Philippe Flandre, David Dunn, et al.
Pageof 51